Inventor · disambiguated record
Harris A. Gelbard
Also filed as: GELBARD HARRIS A
8 granted patents·6 pending applications·33 citations·filing 2006–2024
82Inventor score
Top patents by PatentIndex Score
14 records- 0191US11479541B1Acid addition salts, compositions, and methods of treating thereofPIONEURA CORP·Filed 2022·Granted Oct 25, 2022·3 cites·4 claims
- 0290US8877772B2Substituted pyrrolo[2,3-B]pyridines as MLK inhibitorsGELBARD HARRIS A·Filed 2009·Granted Nov 4, 2014·21 cites·21 claims
- 0378US9814704B2Substituted pyrrolo[2,3-b]pyridines as MLK inhibitorsUNIV ROCHESTER·Filed 2016·Granted Nov 14, 2017·2 cites·23 claims
- 0475US9181247B2Substituted pyrrolo[2,3-B]pyridines as MLK inhibitorsUNIV ROCHESTER·Filed 2014·Granted Nov 10, 2015·2 cites·17 claims
- 0572US10485800B2Mixed lineage kinase inhibitors for HIV/AIDS therapiesUNIV ROCHESTER·Filed 2013·Granted Nov 26, 2019·2 cites·22 claims
- 0672US8846909B2Bicyclic heteroaryl kinase inhibitors and methods of useGELBARD HARRIS A·Filed 2011·Granted Sep 30, 2014·3 cites·19 claims
- 0764US2024376071A1Acid addition salts, compositions, and methods of treating thereofPIONEURA CORP·Filed 2024·Application pending·0 cites
- 0863US11661409B1Acid addition salts, compositions, and methods of treatingPIONEURA CORP·Filed 2022·Granted May 30, 2023·0 cites·6 claims
- 0952US2009221651A1Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damageBELLIZZI MATTHEW J·Filed 2006·Application pending·0 cites
- 1052US2009081318A1Treatment of neuroads using inhibitors of glycogen synthase kinase (gsk)-3GELBARD HARRIS A·Filed 2006·Application pending·0 cites
- 1150US2016024087A1Mlk inhibitors and methods of useUNIV ROCHESTER·Filed 2015·Application pending·0 cites
- 1245US2008269161A1Compositions and Methods Relating to Mitochondrial Hyperpolarization in Neurological DiseasePERRY SETH·Filed 2006·Application pending·0 cites
- 1341US9370515B2Mixed lineage kinase inhibitors and method of treatmentsCALIFIA BIO INC·Filed 2014·Granted Jun 21, 2016·0 cites·19 claims
- 1432US2016228437A1Mixed lineage kinase inhibitors and method of treatmentsCALIFIA BIO INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →